​

Funding Round

Convertible Note - Ashvattha Therapeutics

Convertible Note - Ashvattha Therapeutics

Investment Firm

Overview

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

Announced Date

May 31, 2020

Funding Type

Convertible Note

Highlights

Location

United States, North America

Social

Investor Lead

Natural Capital

Natural Capital

No designation

Participant Investors

10

Investor Name
Participant InvestorBhaskar Ghosh
Participant InvestorPhil Deutch
Participant InvestorPlum Alley
Participant InvestorSam Altman
Participant InvestorSand Hill Angels

Round Details and Background

Ashvattha Therapeutics raised $22000000 on 2020-05-31 in Convertible Note

Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 15, 2019
Series A - Ashvattha Therapeutics
3-7.0M
May 31, 2020
Convertible Note - Ashvattha Therapeutics
12-22.0M
Apr 27, 2022
Series B - Ashvattha Therapeutics
4-69.0M
Apr 24, 2023
Series B - Ashvattha Therapeutics
1-undefined

Recent Activity

There is no recent news or activity for this profile.